4
Changes in Ownership
Attovia Therapeutics, Inc. Filed Acc 0002141590-26-000008
Options or other derivatives
- Chief Business Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Odrowaz Zaneta Chief Business Officer | 2026-08-04 | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | D | ||
Loading xslF345X06/form4-08062026_090834.xml…